File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: The use of aptamer‐conjugated nanoparticles in novel malaria diagnosis platforms
Title | The use of aptamer‐conjugated nanoparticles in novel malaria diagnosis platforms |
---|---|
Authors | |
Issue Date | 2013 |
Citation | The 2013 Hong Kong Inter‐University Biochemistry Postgraduate Symposium, Hong Kong, China, 15 June 2013, abstract no. P29 How to Cite? |
Abstract | The on‐going battle against malaria not only requires novel therapies to combat emerging resistant strains,
but also requires effective point of care diagnosis so that such therapies can be appropriately administered,
especially in underdeveloped regions where the disease is most prevalent. Current point‐of‐care rapid
diagnostics rely on antibody‐based technologies which have drawbacks of cost and stability. Aptamers are
oligonucleotide sequences which are developed to specifically bind desired targets, essentially DNA‐based
antibodies. The stability and cheap manufacture cost of short DNA sequences make aptamers a viable
alternative to antibodies in malaria diagnosis (aptamers are usually < 50 bases in length). The common
malaria antigens which are detected by most malaria diagnosis blood tests are histidine‐rich protein 2 (HRP2)
and Plasmodium falciparum lactose dehydrogenase (PvLDH). Aptamers for these antigens have been
developed, characterised and found to bind with nanomolar affinities. Conjugation of these aptamersto gold
and silver nanoparticles has allowed for visual detection of HRP2 and PvLDH in solution (owing to the visual
properties of metal nanoparticles) and the next step of the project is to incorporate such aptamer‐
functionalised nanoparticles into a paper‐based lateral flow devices for future sensitive, cheap and easy‐to‐
use malaria diagnostics. |
Description | Poster Presentation |
Persistent Identifier | http://hdl.handle.net/10722/186626 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dirkzwager, RM | en_US |
dc.contributor.author | Cheung, YW | en_US |
dc.contributor.author | Tanner, JA | en_US |
dc.date.accessioned | 2013-08-20T12:15:37Z | - |
dc.date.available | 2013-08-20T12:15:37Z | - |
dc.date.issued | 2013 | en_US |
dc.identifier.citation | The 2013 Hong Kong Inter‐University Biochemistry Postgraduate Symposium, Hong Kong, China, 15 June 2013, abstract no. P29 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/186626 | - |
dc.description | Poster Presentation | - |
dc.description.abstract | The on‐going battle against malaria not only requires novel therapies to combat emerging resistant strains, but also requires effective point of care diagnosis so that such therapies can be appropriately administered, especially in underdeveloped regions where the disease is most prevalent. Current point‐of‐care rapid diagnostics rely on antibody‐based technologies which have drawbacks of cost and stability. Aptamers are oligonucleotide sequences which are developed to specifically bind desired targets, essentially DNA‐based antibodies. The stability and cheap manufacture cost of short DNA sequences make aptamers a viable alternative to antibodies in malaria diagnosis (aptamers are usually < 50 bases in length). The common malaria antigens which are detected by most malaria diagnosis blood tests are histidine‐rich protein 2 (HRP2) and Plasmodium falciparum lactose dehydrogenase (PvLDH). Aptamers for these antigens have been developed, characterised and found to bind with nanomolar affinities. Conjugation of these aptamersto gold and silver nanoparticles has allowed for visual detection of HRP2 and PvLDH in solution (owing to the visual properties of metal nanoparticles) and the next step of the project is to incorporate such aptamer‐ functionalised nanoparticles into a paper‐based lateral flow devices for future sensitive, cheap and easy‐to‐ use malaria diagnostics. | - |
dc.language | eng | en_US |
dc.relation.ispartof | Hong Kong Inter‐University Biochemistry Postgraduate Symposium | en_US |
dc.title | The use of aptamer‐conjugated nanoparticles in novel malaria diagnosis platforms | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Tanner, JA: jatanner@hku.hk | en_US |
dc.identifier.authority | Tanner, JA=rp00495 | en_US |
dc.identifier.hkuros | 217913 | en_US |